Form 4: Applied Therapeutics Director Joel S. Marcus Acquires 45,000 Shares of Common Stock

Director Joel S. Marcus acquired 45,000 shares of Applied Therapeutics, Inc. common stock on June 6, 2024, through compensatory Restricted Stock Units.

Summary

• On June 6, 2024, Joel S. Marcus, a director of Applied Therapeutics, Inc., acquired 45,000 shares of common stock.
• The acquisition was made through compensatory Restricted Stock Units (RSUs) granted under the company's 2019 Equity Incentive Plan.
• Each RSU represents a contingent right to receive one share of the issuer's common stock.
• The RSUs vest quarterly from June 6, 2024, until the earlier of the first anniversary of the grant date or the date of the issuer's next annual stockholder meeting, subject to continuous service.
• Following the transaction, Marcus directly owns 498,414 shares of Applied Therapeutics common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by a director is generally a good sign, but it's a routine transaction related to compensation.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future prospects.
• The use of RSUs as compensation aligns the director's interests with those of the shareholders, incentivizing long-term value creation.

Future Outlook

The vesting schedule of the RSUs extends until the earlier of June 6, 2025, or the date of the next annual stockholder meeting, contingent upon continuous service.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders, such as directors and officers, trade in their company's stock. These filings provide transparency to the market and allow investors to track insider activity, which can be an indicator of company performance and management's confidence.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment due to the director's increased stake in the company.

Key Dates